First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies

CHALFONT ST. GILES, England--(BUSINESS WIRE)--Jun 15, 2023--

Related Keywords

United Kingdom ,Netherlands ,Paul Evans ,Debbie Leven ,Ken Herrmann ,Patient Care Solutions ,Ge Healthcare ,Ge Healthcare Technologies Inc ,Head Of Global Research Development ,National Cancer Institute Imaging Steering Committee ,Business Wire ,Section Editor ,Nuclear Medicine ,Global Research ,Pharmaceutical Diagnostics ,Molecular Imaging ,Care Technologies ,Tolerability When Used ,Patients With Solid Tumour ,Vivo Imaging ,Cellular Anti Cancer ,Care Media Contact ,Business ,Ews Ap ,